Tompkins Financial Corp Takes Position in Encompass Health Co. (NYSE:EHC)

Tompkins Financial Corp purchased a new stake in Encompass Health Co. (NYSE:EHC) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 500 shares of the company’s stock, valued at approximately $46,000.

Several other hedge funds have also added to or reduced their stakes in the business. UMB Bank n.a. boosted its stake in Encompass Health by 387.7% in the 3rd quarter. UMB Bank n.a. now owns 317 shares of the company’s stock valued at $31,000 after purchasing an additional 252 shares during the period. V Square Quantitative Management LLC lifted its holdings in shares of Encompass Health by 53.0% during the third quarter. V Square Quantitative Management LLC now owns 404 shares of the company’s stock worth $39,000 after buying an additional 140 shares in the last quarter. Avior Wealth Management LLC bought a new stake in shares of Encompass Health in the third quarter valued at about $40,000. Benjamin F. Edwards & Company Inc. grew its stake in shares of Encompass Health by 58.9% in the second quarter. Benjamin F. Edwards & Company Inc. now owns 534 shares of the company’s stock valued at $46,000 after acquiring an additional 198 shares in the last quarter. Finally, Point72 Asia Singapore Pte. Ltd. bought a new position in Encompass Health during the second quarter worth about $58,000. Institutional investors and hedge funds own 97.25% of the company’s stock.

Encompass Health Stock Up 0.3 %

EHC stock opened at $94.68 on Friday. The firm has a 50-day moving average price of $97.39 and a 200-day moving average price of $93.94. Encompass Health Co. has a 12 month low of $69.76 and a 12 month high of $104.55. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.88. The stock has a market capitalization of $9.54 billion, a P/E ratio of 22.87, a price-to-earnings-growth ratio of 1.09 and a beta of 0.89.

Encompass Health (NYSE:EHC) last issued its quarterly earnings data on Monday, October 28th. The company reported $1.03 EPS for the quarter, beating the consensus estimate of $0.94 by $0.09. The business had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.33 billion. Encompass Health had a net margin of 8.10% and a return on equity of 17.60%. The firm’s revenue was up 11.9% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.86 EPS. As a group, equities research analysts anticipate that Encompass Health Co. will post 4.29 EPS for the current fiscal year.

Analysts Set New Price Targets

EHC has been the topic of a number of analyst reports. Barclays increased their target price on shares of Encompass Health from $109.00 to $116.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 29th. KeyCorp raised their price objective on Encompass Health from $115.00 to $117.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 29th. UBS Group upped their target price on Encompass Health from $100.00 to $110.00 and gave the company a “buy” rating in a research report on Wednesday, September 25th. Royal Bank of Canada raised their price target on Encompass Health from $105.00 to $110.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 30th. Finally, Truist Financial reaffirmed a “buy” rating and set a $116.00 price objective (up previously from $108.00) on shares of Encompass Health in a research report on Wednesday, October 30th. Nine research analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, Encompass Health presently has a consensus rating of “Buy” and a consensus target price of $107.11.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.